Accel Brands (ACLP) 10-Q/A 7 Jul 14 2014 Q2 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Dec. 31, 2013	Apr. 03, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'AccelPath, Inc.	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Entity Central Index Key	'0001077800	'
Current Fiscal Year End Date	'--06-30	'
Entity Common Stock, Shares Outstanding	'	992,549,380
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'Yes	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

BALANCE_SHEETS_Unaudited

BALANCE SHEETS (Unaudited) (USD $)	Dec. 31, 2013	Jun. 30, 2013
CURRENT ASSETS	'	'
Cash and cash equivalents	$4,039	$1,201
Total current assets	4,039	1,201
Investment in Unconsolidated Subsidiary	1,039,074	0
Property and equipment - net	69,159	78,719
Total Non-current assets	169,159	0
Total assets	1,112,270	79,920
Current Liabilities	'	'
Accounts payable	1,261,579	1,261,579
Accrued expenses and other current liabilities	806,172	759,702
Accrued compensation	306,555	306,555
Current portion of notes payable- net of discounts of $181,629 and $12,219 at December 31, 2013 and June 30, 2013 , respectively	668,776	384,785
Total current liabilities	3,043,082	2,712,621
Long-term portion of notes payable- net of discounts of $0 and $31,400 at December 31, 2013 and June 30, 2013 , respectively	0	116,954
TOTAL LIABILITIES	3,043,082	2,829,575
STOCKHOLDERS' DEFICIT	'	'
Preferred stock- Series E 5% Convertible; stated value $1,000 per share; -0- and 100 shares issued and outstanding at December 31, 2013 and June 30, 2013, respectively (preference in liquidation at December 31, 2013 and June 30, 2013 of $-0- and $115,239 brespectively	0	100,000
Preferred stock- Series F Convertible; stated value $1,000 per share; 90 shares issued and outstanding at December 31, 2013 and JUNE 30, 2013 .	90,000	90,000
Preferred stock- Series G Convertible; stated value $1,000 per share; No shares issued and outstanding at DECEMBER 31, 2013 and june 30, 2013	0	0
Preferred stock- Series H Convertible; stated value $1,000 per share; 51 shares issued and outstanding at December 31 , 2013 and June 30, 2013	0	0
Preferred stock- Series I Convertible; stated value $1,000 per share; 3,500 and -0- shares issued and outstanding at December 31, 2013 and June 30, 2013, respectively. Stated value $1,000 per share, 3,500 shares authorized	4	0
Common stock, $0.001 par value, 995,000,000 shares authorized;992,549,380 and 360,385,085 issued and outstanding at December 31, 2013 and June 30, 2013, respectively	992,549	360,385
Additional paid-in capital	5,735,635	4,372,168
Accumulated deficit	-8,546,923	-7,470,132
TOTAL STOCKHOLDERS'(DEFICIT) of AccelPath, Inc.	-1,728,735	-2,547,579
Non-Controlling interest	-202,077	-202,077
Total stockholders' (deficit)	-1,930,812	-2,749,656
Total liabilities and stockholders' (deficit)	$1,112,270	$79,919

BALANCE_SHEETS_PARENTHETICALS_

BALANCE SHEETS PARENTHETICALS (Unaudited) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Parentheticals	'	'
Common Stock, par value	$0.00	$0.00
Common Stock, Shares Authorized	995,000,000	995,000,000
Common Stock, Shares Issued	992,549,380	360,385,085
Common Stock, Shares Outstanding	992,549,380	360,385,085
Preferred stock- Series E 5% Convertible stated value per share	$1,000	$1,000
Preferred stock- Series E 5% Convertible shares issued	0	100
Preferred stock- Series E 5% Convertible shares outstanding	0	100
Preference in liquidation shares amounted	$0	$115,239
Preferred stock- Series F Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series F Convertible; shares issued	90	90
Preferred stock- Series F Convertible; shares outstanding	90	90
Preferred stock- Series G Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series G Convertible; shares issued	0	0
Preferred stock- Series G Convertible; shares outstanding	0	0
Preferred stock- Series H Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series H Convertible; shares issued	51	51
Preferred stock- Series H Convertible; shares outstanding	51	51
Preferred stock- Series I Convertible; stated value per share	$1,000	$1,000
Preferred stock- Series I Convertible; shares issued	3,500	0
Preferred stock- Series I Convertible; shares outstanding	3,500	0
Preferred stock- Series I Convertible; Authorised	3,500	3,500
Net discount of long term notes payable	0	31,400
Net discount of Current notes payable	$181,629	$12,219

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement	'	'	'	'
Revenues	$54,000	$136,723	$108,000	$191,706
Cost of Revenues	0	0	0	0
Gross Profits	54,000	136,723	108,000	191,706
Operating Expenses	'	'	'	'
Selling General and Administrative Expenses	367,007	315,320	712,523	836,710
Total Operating Expenses	367,007	315,320	712,523	836,710
Operating Loss	-313,007	-178,597	-604,523	-645,004
Other Income (Expense)	'	'	'	'
Interest expense	-101,709	-68,543	-167,932	-133,468
Loss on Conversion of Debt	-310,836	0	-310,836	0
Loss on terminated acquisition	0	-30,648	0	-30,648
Technology licensing Income	0	22,761	6,501	33,001
Total Other (Expense) - net	-412,545	-76,430	-472,268	-131,115
Net Income (Loss)	-725,552	-255,027	-1,076,791	-776,119
Net income (Loss) attributable to non-controlling interest	0	1,782	0	17,475
Net Income (Loss) Accelpath, Inc	-725,552	-253,245	-1,076,791	-758,644
Deemed and cash dividends to Preferred Stockholders	0	-1,278	-1,139	-362,806
Net loss applicable to Common shareholders	($725,552)	($254,523)	($1,077,930)	($1,121,450)
Net loss per common share - basic and diluted	($0.00)	($0.00)	($0.00)	($0.01)
Weighted average number of common shares outstanding during the period/year - basic and diluted.	656,577,548	150,512,493	517,549,470	138,566,142

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders Equity (Deficit) (USD $)	Series E Preferred stock	Series F Preferred stock	Series G Preferred stock	Series H Preferred stock	Series I Preferred stock	Common Stock Shares	Common Stock Amount	Additional Paid-In Capital	Accumulated Deficit	Non-Controlling Interest in Subsidiary	Total Stockholders' Equity (Deficit)
	USD ($)	USD ($)		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Jun. 30, 2011	300,000	0	0	0	0	120,279,296	120,279	2,917,952	-3,437,130	-187,291	-286,190
Sale of Common stock	'	'	'	'	'	1,047,634	1,048	33,592	'	'	34,640
Deferred stock issuance costs	'	'	'	'	'	'	'	($36,000)	'	'	($36,000)
Warrants issued with convertible notes payable	'	'	'	'	'	'	'	49,005	'	'	49,005
Restricted stock award	'	'	'	'	'	'	'	29,167	'	'	29,167
Conversion of 100 shares of preferred stock- Series E to common stock	-100,000	'	'	'	'	2,251,390	2,251	97,749	'	'	'
Cash dividends accrued on preferred stock - Series E	'	'	'	'	'	'	'	-13,360	'	'	-13,360
Stock based Compensation	'	'	'	'	'	'	'	494,989	'	'	494,989
Net loss	'	'	'	'	'	'	'	'	-2,056,310	2,689	-2,053,621
Restricted stock award	'	'	'	'	'	'	'	29,167	'	'	29,167
Balance at Jun. 30, 2012	200,000	'	'	'	'	123,578,320	123,578	3,573,094	-5,493,440	-184,602	-1,781,370
Sale of Common stock	'	'	'	'	'	701,754	702	5,298	'	'	6,000
Sale of 90 shares of Series F Preferred Stock	'	90,000	'	'	'	'	'	'	'	'	90,000
Warrants issued for Convertible notes payable	'	'	'	'	'	'	'	5,410	'	'	5,410
Beneficial conversion feature on notes payable	'	'	'	'	'	'	'	133,222	'	'	133,222
Restricted stock award	'	'	'	'	'	2,500,000	2,500	18,333	'	'	20,833
Conversion of notes payable to common stock	'	'	'	'	'	236,809,509	236,810	53,111	'	'	289,920
Rescission of common shares issued at par	'	'	'	'	'	-3,204,498	-3,204	3,204	'	'	'
Conversion of 100 shares of Series E Preferred Stock to note payable	-100,000	'	'	'	'	'	'	'	'	'	-100,000
Cash dividends accrued on Series E Preferred stock	'	'	'	'	'	'	'	-5,617	'	'	-5,617
Issuance of Series H Preferred stock	'	'	'	'	'	'	'	60,000	'	'	60,000
Stock-based compensation	'	'	'	'	'	'	'	526,113	'	'	526,113
Net loss	'	'	'	'	'	'	'	'	-1,976,692	-17,475	-1,994,167
Balance at Jun. 30, 2013	100,000	90,000	'	'	'	360,385,085	360,385	4,372,168	-7,470,132	-202,077	-2,749,656
Beneficial conversion feature on notes payable	'	'	'	'	'	'	'	274,000	'	'	274,000
Conversion of 100 shares of Series E Preferred Stock to note payable	-100,000	'	'	'	'	'	'	'	'	'	-100,000
Cash dividends accrued on Series E Preferred stock	'	'	'	'	'	'	'	-1,139	'	'	-1,139
Stock-based compensation	'	'	'	'	'	'	'	267,402	'	'	267,402
Shares issued for conversion of debt	'	'	'	'	632,164,295	632,164,295	632,164	-215,867	'	'	416,297
Issuance of Series I Preferred	'	'	'	4	99,996	'	100,000	99,996	'	'	100,000
Net loss	'	'	'	'	'	'	'	'	($1,076,791)	'	($1,076,791)
Balance at Dec. 31, 2013	'	90,000	'	4	992,549,380	992,549,380	992,549	5,735,635	-8,546,923	-202,077	-1,930,812

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($1,076,791)	$776,119
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Loss from Conversion of debt	310,836	0
Stock based Compensation	267,402	258,711
Depreciation and amortization of property and equipment	9,560	5,396
Amortization of note payable discount	139,486	96,898
Warrants issued for note payable extension	0	3,431
Restricted Stock Award Expense	0	20,833
Accrual of Original Issue Discount	3,214	0
Accrued interest and legal fees issued for notes	3,426	0
Accrued dividends converted to notes payable	13,143	0
Reduction in liabilities for issuance of common stock	12,091	0
Fair value of comnmon stock issued under ESA	0	0
Changes in operating assets and liabilities:	'	'
Decrease (increase) in Accounts receivable	0	-90,236
Decrease (Increase) in Deposits, prepaid expenses and other assets	0	2,000
Increase (decrease) in accounts payable	0	-293
Increase (decrease) in Accrued Expenses and other liabilities	46,471	-2,259
Increase in Accrued compensation	0	6,040
Liabilities related to discontinued operations	0	-638,308
Net cash provided by (used in) operating activities	-271,162	-979,739
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Restricted cash	0	638,304
Purchase of property and equipment	0	-28,200
Net cash used in investing activities	0	610,104
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Proceeds from issuance of notes payable and common stock warrants	274,000	266,700
Proceeds from issuance of Series F Preferred stock	0	90,000
Proceeds from issuance of common stock	0	6,000
Net cash provided by financing activities	274,000	362,700
Net (Decrease) in Cash	2,838	-6,935
Cash - Beginning of Period/Year	1,201	16,404
Cash - End of Period/Year	4,039	9,469
Cash paid during the period/year for:	'	'
Interest	0	12,062
Income Taxes	0	0
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Fair value of common stock warrants issued with convertible notes payable	0	1,979
Fair value of beneficial conversion feature on notes payable	274,000	99,889
Notes payable and accrued interest converted to common stock	91,171	77,007
Preferred Stock- Series E converted to Notes payable, including accrued dividends of $14,282 and $5,834, respectively for December 31, 2013 and December31, 2012	114,282	0
Cash dividend accrued on Preferred Stock-Series E	1,139	2,806
Issuance of Preferred Stock- Series I for Investment in unconsolidated subsidiary	$1,039,074	$0

CASH_FLOWS_PARENTHETICALS_Unau

CASH FLOWS PARENTHETICALS (Unaudited) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS PARENTHETICALS	'	'
Preferred Stock- Series E accured dividends	$14,282	$5,834

NATURE_OF_OPERATIONS_AND_BASIS

NATURE OF OPERATIONS AND BASIS OF PRESENTATION	6 Months Ended
	Dec. 31, 2013
NATURE OF OPERATIONS AND BASIS OF PRESENTATION	'
NATURE OF OPERATIONS AND BASIS OF PRESENTATION	'
	1.  NATURE OF OPERATIONS AND BASIS OF PRESENTATION
	Business
	AccelPath, Inc. (formerly - Technest Holdings, Inc.) (the “Company”) includes its wholly-owned subsidiaries AccelPath, LLC (“AccelPath”) and Genex Technologies, Inc. (“Genex”), and its 49% owned subsidiary Technest, Inc. (“Technest”) (see Basis of Presentation below).  See Digipath Solutions, LLC (“Digipath”) discussion below.  The Company has two primary businesses: AccelPath is in the business of enabling pathology diagnostics and Technest was in the business of the design, research and development, integration, sales and support of three-dimensional imaging devices and systems.
	Name Change and Domicile Change
	On February 7, 2012, the Board of Directors approved and recommended a change in the parent company’s name from Technest Holdings, Inc. to AccelPath, Inc. and a change in the domicile of the Company from Nevada to Delaware.  The name change and domicile change became effective on May 2, 2012.
	Digipath Solutions, LLC
	On September 18, 2012, the Company entered into an agreement to acquire all of the outstanding membership interests of Digipath, from its sole member pursuant to an Equity Purchase Agreement among the Company, Digipath and Mr. Rishi Reddy (the “Purchase Agreement”). In accordance with the Purchase Agreement, the Company issued Mr. Reddy a convertible promissory note in the amount of $1,050,000 (the “Note”), 1,250 shares of Series G Preferred Stock (the “Shares”), and agreed to make a cash payment totaling $100,000, $500 of which was paid at closing and $49,500 was paid on October 31, 2012 by Digipath.  In addition, Mr. Reddy entered into a one-year consulting agreement with the Company pursuant to which he agreed to perform consulting and advisory services in the field of pathology and to serve as a member of the Company’s Medical Advisory Board for a monthly retainer of $8,333.
	On February 15, 2013, due to information that came to light subsequent to September 18, 2012, the Company and Mr. Reddy entered into a Rescission Agreement, whereby the Purchase Agreement was cancelled and all parties were restored to their status before the Purchase Agreement was executed (the “Rescission”).  As a result of the Rescission, the Company returned to Mr. Reddy all of the outstanding membership interests of Digipath and Mr. Reddy returned to the Company, the Note, the Shares and all cash payments received to date.  The consulting and advisory services arrangement between the Company and Mr. Reddy was canceled.  The Company also recognized a loss on the terminated acquisition of $30,648 for the six months ended December 30, 2012.
	Energy Innovative Products (“EIP”)
	AccelPath and EIP have entered into an Agreement and Plan of Reorganization dated as of October 24, 2013, which will result in EIP becoming a wholly-owned subsidiary of AccelPath.  It is expected that the equity holders of EIP will become the holders of approximately 76% of the total outstanding capital stock, on a fully diluted basis, upon completion of the transaction.  For accounting and financial reporting purposes under Securities and Exchange Commission rules, the transaction is expected to be treated as a reverse merger.  Management of EIP will become management of AccelPath upon completion of the transaction.  A majority of the Board of Directors of the post-merger company will be represented by persons associated with EIP.
	The transaction will be undertaken in two steps.  In the initial step, completed on Friday, October 25, 2013, AccelPath acquired, from EIP, shares of Common Stock of EIP representing 19% of the issued and outstanding Common Stock in return for 3,500 shares of a newly created Series I Preferred Stock of AccelPath.  The Series I Preferred Stock will be convertible 120 after the closing of the merger into 14% of AccelPath’s common stock on a fully diluted basis and is redeemable by AccelPath at its issue price plus any accrued dividends.  The transaction is intended to be a tax free merger under Section 368 (a)(1)(B) of the Internal Revenue Code and for accounting purposes, will be treated as a reverse merger.  At the final closing of the transaction AccelPath expects to change its corporate name to reflect the business operations of EIP.
	Consummation of the merger is subject to usual and customary closing conditions.  In addition, the parties must satisfy several other closing conditions in order to complete the merger transaction.  AccelPath is required to undertake a recapitalization and restructuring of its equity and debt on terms satisfactory to EIP, the parties are required to obtain necessary shareholder approvals for the proposed reverse merger as may be required under state law.  Both AccelPath and EIP are required to complete audited and unaudited financial statements to allow for the filing of Form 8-K in accordance with the requirements of the Securities and Exchange Act of 1934, as amended, and SEC rules and regulations and AccelPath must be current in its Securities and Exchange Act filings.  The parties expect to undertake a reverse stock split of the post merger company’s combined equity to be effective at the time of closing of the merger.
	The Company accounts for its investment in EIP under the Cost method and includes it under the caption, Investment in Unconsolidated subsidiary. The Company evaluates its investment in EIP for impairment quarterly.  At December 31, the Company determined that no impairment charge was necessary.  Based upon a report of an independent valuation analyst, the Company valued its investment in EIP at $1,039,074 at December 31, 2013..
	Basis of Presentation
	The accompanying consolidated financial statements include the operations of the Company, its wholly-owned subsidiary AccelPath, its inactive wholly-owned subsidiary Genex, and its 49% owned subsidiary Technest.  Technest became inactive in the three months ending September 30, 2012.  Technest previously conducted research and development in the field of computer vision technology and the Company has the right of first refusal to commercialize products resulting from this research and development.  The Company’s former Chief Executive Officer beneficially owns 23% of Technest, an employee owns 23% and an unrelated a third party owns 5%.  Technest is considered a variable interest entity (VIE) for which the Company is the primary beneficiary.
	The Company consolidates all entities in which the Company holds a “controlling financial interest.” For voting interest entities, the Company is considered to hold a controlling financial interest when the Company is able to exercise control over the investees’ operating and financial decisions. For variable interest entities (“VIEs”), the Company is considered to hold a controlling financial interest when it is determined to be the primary beneficiary. For VIEs, a primary beneficiary is a party that has both: (1) the power to direct the activities of a VIE that most significantly impact that entity's economic performance, and (2) the obligation to absorb losses, or the right to receive benefits, from the VIE that could potentially be significant to the VIE. The determination of whether an entity is a VIE is based on the amount and characteristics of the entity's equity.
	All significant inter-company balances and transactions have been eliminated in consolidation.
	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, without being audited, pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments considered necessary to make the financial statements not misleading have been included. Operating results for the three months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending June 30, 2013. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended June 30, 2012 filed with the Securities and Exchange Commission.
	Recent Accounting Pronouncements
	There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on the Company’s consolidated financial statements.

GOING_CONCERN_UNCERTAINTY_AND_

GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN	6 Months Ended
	Dec. 31, 2013
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN:	'
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN	'
	2.  GOING CONCERN UNCERTAINTY AND MANAGEMENT’S PLAN
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate the continuation of the Company as a going concern. The Company had a net loss applicable to common shareholders of $1,076,791 for the six months ended December 31, 2013 and a net loss applicable to common shareholders of $2,342,309 for the year ended June 30, 2013.  Further, the Company had a working capital deficit of $3,039,043 and a stockholders’ deficit of $1,930,812 at December 31, 2013.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	Management is anticipating revenue growth through expansion of its customer base, and is also actively seeking financing through new and existing investors to fund operations. There is no assurance that the Company can reverse its net losses, or that the Company will be able to raise capital. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTES_PAYABLE

NOTES PAYABLE	6 Months Ended
	Dec. 31, 2013
NOTES PAYABLE	'
NOTES PAYABLE	'
	3.  NOTES PAYABLE
	Notes payable – related parties and a third parties consist of the following:
		December 31,		June 30,
		2013		2013
	Note payable – former Managing Member	$	27,750	$	27,750
	Note payable – related corporation		4,300		4,300
	Notes payable – stockholders		13,000		13,000
	Convertible notes payable		805,355		500,308
	Total		850,405		545,358
	Convertible notes payable, discount		-181,629		-43,619
	Total, net of discount		668,776		501,739
	Less current portion		668,776		384,785
	Long-term debt	$	-0-	$	116,954
	Maturities of notes payable for the years ending June 30, 2014 and 2015 are $634,003 and $216,402 respectively.
	On March 4, 2011, AccelPath entered into a resignation and repurchase agreement with one of its Managing Members.  The Managing Member resigned on March 4, 2011 and AccelPath agreed to repurchase 10,498,120 shares of $0.001 par value common stock for $74,000.  To complete the repurchase, AccelPath issued a $74,000 note payable due in eight monthly installments of $9,269 including interest at 0.54% per annum.  At December 31, 2013, AccelPath has not paid $27,750 of principal payments due for August through October 2011.  During a default, unpaid principal bears interest at 12% per annum.  In addition, AccelPath entered into a consulting agreement with the Managing Member requiring payments of $750 per month for a period of eight months in consideration for continuing services.  Included in accrued expenses at the Balance sheet date are $2,250 of consulting payments due for August through October 2011.
	On August 18, 2011, the Company borrowed $3,300 from a corporation controlled by our Chief Executive Officer. The Company borrowed an additional $1,000 on January 12, 2012.  The note is payable on demand and accrues interest at a rate of 0.32% per annum.
	During the three months ended September 30, 2012, the Company borrowed $15,000 from a stockholder.  On February 27, 2012, the Company repaid $2,000 of the note payable - stockholder. The balance of this note is payable on demand and accrues interest at 0.19% per annum. On October 1, 2012, the Company borrowed $100,000 from a stockholder.  The loan will be repaid with three monthly payments of $23,000 beginning May 1, 2014 and ending on October 1, 2014 for a total payment amount of $138,000.
	During the three months ended September 30, 2012, the Company borrowed $5,000 from our Chief Executive Officer.  During the three months ended September 30, 2013, the Company borrowed an additional $34,700 from our Chief Executive Officer.  The balance of these notes are payable on demand and accrue interest at 0.19% per annum.
	On February 10, 2012, the Company borrowed $40,000 from a third party under a promissory note which matured on August 31, 2012.  The note bears interest at 8% per annum and includes a redemption premium of $6,000 due on the maturity date.  The redemption premium is being accrued over the term of the note as additional interest.
	On February 10, 2012, the Company borrowed $50,000 from a a third party.  The Company repaid $5,000 of the note on March 12, 2012.  The convertible promissory note bears interest at 5% per annum and matured on August 10, 2012.  The Company has the option to pay the interest with its common stock at the closing bid price immediately prior to the due date and the investor has the option to convert the promissory note into shares of common stock at the closing bid price (but not less than $0.01 per share) immediately prior to the conversion date.  The Company also issued the investor a five-year warrant to purchase 500,000 shares of common stock at an exercise price of $0.01 per share.  The warrant includes a cashless net exercise provision and has piggyback registration rights for the shares of common stock underlying the warrant and the shares of common stock issuable pursuant to the note.  The Company allocated $8,037 of the proceeds to the warrant and $41,963 of the proceeds to the discounted value of the note based on their relative fair values.  On October 2, 2012, the Company entered into an amendment to the agreement to extend the maturity date to November 10, 2012 in exchange for a payment of $2,000 and the issuance of a warrant to purchase 250,000 shares of common stock at an exercise price of $0.01 per share.  The Company evaluated the modification of the note and determined that it did not qualify as a debt extinguishment.  Consequently, the $3,431 fair value of the warrant was recognized as an additional debt discount and fully amortized to interest expense during the three months ended September 30, 2013.  The $2,000 payment was made in January 2013.
	On February 17, 2012, the Company borrowed $100,000 from a a third party.  The convertible promissory note bears interest at 5% per annum and matures on August 16, 2013.  The Company has the option to pay the interest with its common stock at the closing bid price immediately prior to the due date.  The investor has the option to convert the promissory note into shares of common stock at the closing bid price (but not less than $0.01 per share) immediately prior to the conversion date.  In addition, the Company has the option to convert the promissory note into shares of common stock at the closing bid price 30 days prior to the maturity date if the price per share is at least $0.01. The Company also issued the investor a five-year warrant to purchase 1,000,000 shares of common stock at an exercise price of $0.01 per share.  The warrant includes a cashless net exercise provision.  The Company granted piggyback registration rights for the shares of common stock underlying the warrant and the shares of common stock issuable pursuant to the note.  The Company allocated $32,743 of the proceeds to the warrant and $67,257 of the proceeds to the discounted value of the note based on their relative fair values.
	On April 18, 2012, the Company borrowed $50,000 from a a third party.  The convertible promissory note bears interest at 5% per annum and matures on October 17, 2013.  The Company has the option to pay the interest with its common stock at the closing bid price immediately prior to the due date.  The investor has the option to convert the promissory note into shares of common stock at the closing bid price (but not less than $0.01 per share) immediately prior to the conversion date.  In addition, the Company has the option to convert the promissory note into shares of common stock at the closing bid price 30 days prior to the maturity date if the price per share is at least $0.01. The Company also issued the investor a five-year warrant to purchase 500,000 shares of common stock at an exercise price of $0.01 per share.  The warrant includes a cashless net exercise provision and the investor has piggyback registration rights for the shares of common stock underlying the warrant and the shares of common stock issuable pursuant to the note.   The Company allocated $8,225 of the proceeds to the warrant and $41,775 of the proceeds to the discounted value of the note based on their relative fair values.
	On July 18, 2012, the Company entered into a subscription agreement with a third party ("a third party") for the purchase of a convertible promissory note in the aggregate principal amount of $100,000. The note accrues interest at a rate of 5% per annum and became due on January 31, 2013.  The Company is in default of this note. a third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price of $0.0075 per share.  The Company recorded a beneficial conversion discount of $29,333 based on the fair value of the common stock into which the note was convertible to on the commitment date and allocated $70,667 of the proceeds to the discounted value of the note.
	On July 18, 2012, the Company entered into an agreement with a third party to exchange 100 shares of Series E Preferred Stock and accrued dividends of $5,834 into a convertible promissory note in the principal amount of $105,834. The note accrues interest at a rate of 5% per annum and is due on September 1, 2013.  a third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 60% of the current market price. The Company recorded a beneficial conversion discount of $70,556 based on the fair value of the common stock into which the note is convertible to and allocated $35,278 of the proceeds to the discounted value of the note.  During the three months ended September 30, 2013, a third party converted the entire principal value of the note plus $1,692 of accrued interest into 48,770,841 shares of common stock.
	On July 31, 2012, the Company borrowed a total of $7,000 from two individuals.  The convertible promissory notes bear interest at 5% per annum and mature on January 31, 2014.  The Company has the option to pay the interest with its common stock at the closing bid price immediately prior to the due date.  The investors have the option to convert the promissory note into shares of common stock at the closing bid price (but not less than $0.01 per share) immediately prior to the conversion date.  In addition, the Company has the option to convert the promissory notes into shares of common stock at the closing bid price 30 days prior to the maturity date if the price per share is at least $0.01. The Company also issued the investors a five-year warrant to purchase a total of 70,000 shares of common stock at an exercise price of $0.01 per share.  The warrants include a cashless net exercise provision and the investors have piggyback registration rights for the shares of common stock underlying the warrant and the shares of common stock issuable pursuant to the notes.  The Company allocated $443 of the proceeds to the warrants and $6,557 of the proceeds to the discounted value of the note based on their relative fair values.  In August 2012, the investors converted their notes into a total of 700,000 shares of common stock.
	On September 14, 2012, the Company borrowed $25,000 from a stockholder.  The convertible promissory note bears interest at 5% per annum and matures on March 14, 2014.  The Company has the option to pay the interest with its common stock at the closing bid price immediately prior to the due date.  The investor has the option to convert the promissory note into shares of common stock at the closing bid price (but not less than $0.01 per share) immediately prior to the conversion date.  In addition, the Company has the option to convert the promissory notes into shares of common stock at the closing bid price 30 days prior to the maturity date if the price per share is at least $0.01. The Company also issued the investor a five-year warrant to purchase a total of 250,000 shares of common stock at an exercise price of $0.01 per share.  The warrant includes a cashless net exercise provision and the investor has piggyback registration rights for the shares of common stock underlying the warrant and the shares of common stock issuable pursuant to the note.  The Company allocated $1,536 of the proceeds to the warrants and $23,464 of the proceeds to the discounted value of the note based on their relative fair values.
	On March 22, 2013, the Company borrowed $35,000 from a a third party.  The convertible promissory note bears interest at 5% per annum and matures on December 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the ten days prior to the converison. The Company recorded a beneficial conversion discount of $23,333 based on the fair value of the common stock into which the note is convertible to and allocated $11,667 of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On May 13, 2013, the Company borrowed $10,000 from a third party.  The convertible promissory note bears interest at 5% per annum and matures on December 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the ten days prior to the conversion. The Company recorded a beneficial conversion discount of $10,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On July 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on January 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On August 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on February 28, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On September 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on March 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On September 5, 2013, an Investor advanced the Company $15,000 in a Promissory Note.  The Promissory Note has a one year term, an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The Promissory Note has a face value of $17,500, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date.
	On September 20, 2013, an Investor exchanged its remaining interest,$100,000, in the Series E 5% convertible Preferred stock plus accrued dividends of $14,282 into a new Secured Note for $114,282.  The Secured Note matures on September 30, 2014 and has an interest rate of five percent.    Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date.
	On October 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on April 30, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On October 9, 2013, the Company issued a note for $79,000 for fees.  The Promissory Note matures on July 9, 2014 ,has an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The Promissory Note has a face value of $86,900, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date
	On November 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on May 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On December 1, 2013, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on June 30, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	Beneficial Conversion Feature on Notes Payable
	The Company evaluated whether the convertible promissory notes contain a beneficial conversion feature (BCF) and determined that certain of the notes contained a BCF.   The Company also evaluated the terms of the convertible promissory notes and the related warrants issued with the notes under Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 815-15 and determined that these instruments do not require derivative accounting treatment.
	Interest Expense
	Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the Original Issue Discount, was $101,709  and $68,543for the three months ended Deceember 31, 2013 and 2012, respectively. Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the redemption premium, was $167,932  and $133,468 for the six months ended December 31, 2013 and 2012, respectively.

PREFERRED_STOCK

PREFERRED STOCK	6 Months Ended
	Dec. 31, 2013
PREFERRED STOCK	'
PREFERRED STOCK	'
	4.  PREFERRED STOCK
	Series E
	During the quarter ended September 30, 2013,, the Company exchanged its remaining 100 shares of Series E Preferred Stock plus $14,282 of accrued dividends into a new Secured Note of $114,282 (See Footnote Three above)  As of December 31, 2013, the Company has -0- outstanding shares of its Series E 5% Convertible Preferred Stock outstanding.   The Company accrued cash dividends payable of $-0- and $1,278 for the three months ended December 31, 2013 and 2012, respectively.  The Company accrued cash dividends payable of $1,139 and $2,806 for the six months ended December 31, 2013 and 2012, respectively. At December 31, 2013, there are no accrued dividends payable included in accrued expenses and other current liabilities.
	Series F
	On September 7, 2012, the Company authorized 100 shares of Series F Convertible Preferred Stock, with a stated value of $1,000.  The Series F Preferred is convertible into common stock at any time at the option of the holder.  The number of shares of common stock into which one share of Series F Preferred is convertible is determined by (i) dividing $1,000 (the stated value) outstanding by the closing bid price on the trading day immediately prior to the date of the conversion notice (the “Conversion Price”), and (ii) multiplying by ten; provided that if the closing bid price on such trading day is less than $0.02 per share, then the Conversion Price shall be $0.02.  Accordingly, the authorized 100 shares of Series F Preferred are currently convertible into 50,000,000 shares of common stock using a Conversion Price of $0.02.
	On September 10, 2012, the Company issued 90 shares of its Series F Preferred Stock for the purchase price of $90,000 to certain existing investors of the Company.  The 90 shares of Series F Preferred are currently convertible into 45,000,000 shares of common stock. The Company determined that there was a beneficial conversion feature of $360,000 for the issuance of the 90 shares of Series F Preferred Stock.  The beneficial conversion feature was calculated based on the effective conversion price per share compared to the fair value per share of common stock on the commitment date.  This resulted in a deemed dividend in the amount of $360,000 for the three months ended September 30, 2013.
	Series G
	On September 18, 2012, the Company authorized 1,250 shares of Series G Convertible Preferred Stock, with a stated value of $1,000.  The Series G Preferred is convertible into common stock at any time at the option of the holder three months after the date of issuance. After five years from the date of issuance or upon a change of control, the Series G Preferred is automatically converted into shares of common stock. The number of shares of common stock into which one share of Series G Preferred is convertible is determined by dividing $1,000 (the stated value) outstanding by the closing bid price on the trading day immediately prior to the date of the conversion notice (the “Conversion Price”); provided that if the closing bid price on such trading day is less than $0.02 per share, then the Conversion Price shall be $0.02. Accordingly, the authorized 1,250 shares of Series G Preferred are convertible into 62,500,000 shares of common stock at an assumed Conversion Price of $0.02.  As of December 31, 2013 and 2012, there was not Series G Convertible Preferred Stock issued and outstanding.
	Series H
	The number, designation, rights, preferences and privileges of the Series H Preferred were established by the Board at a meeting on April 2, 2013.  The designation, rights, preferences and privileges that the Board established for the Series H Preferred is set forth in a Certificate of Designation that was filed with the Secretary of State of the State of Delaware on April 3, 2013. Among other things, the Certificate of Designation provides that each one share of Series H Preferred has voting rights equal to (x) 0.019607  multiplied by  the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the "Numerator"),  divided by  (y) 0.49,  minus  (z) the Numerator.
	At a meeting of the Board, the Board issued an aggregate of fifty one (51) shares of Series H Preferred to one individual,   Shekhar Wadekar, Chief Executive Officer of the Company.  As a result of the voting rights granted to the Series H Preferred, the Series H Stockholder holds in the aggregate approximately 50.9989% of the total voting power of all issued and outstanding voting capital of the Company
	On March 21, 2014, ownership of the Series H Preferred was transferred to Mr. Steedley, our Chief Executive Officer.
	As of the Balance sheet date, the Series H Preferred is convertible into 506,091,003 shares of common stock.
	Series I
	The number, designation, rights, preferences and privileges of the Series I Preferred were established by the Board. The designation, rights, preferences and privileges that the Board established for the Series I Preferred is set forth in a Certificate of Designation that was filed with the Secretary of State of the State of Delaware on October 30, 2013. Among other things, the Certificate of Designation provides that the Series I may be convertible into 14% of the outstanding shares of the Company on a fully diluted basis.
	As of the filing date of this report, 3,500 shares issued and outstanding of the Series I Preferred.
	See Footnote 1 under Energy Innovative Products  for more detail.

COMMON_STOCK

COMMON STOCK	6 Months Ended
	Dec. 31, 2013
COMMON STOCK:	'
COMMON STOCK	'
	5.  COMMON STOCK
	On March 7, 2011, the Company entered into an Equity Purchase Agreement..  Pursuant to the Equity Purchase Agreement, a third party commited to purchase up to $5,000,000 of common stock over the course of 24 months commencing on the effective date of the registration statement pursuant to the registration rights agreement.  The registration statement was declared effective on February 9, 2012. The purchase price of the common stock to be sold pursuant to the Equity Purchase Agreement will be 95% of the average of the lowest three closing bid prices, consecutive or inconsecutive, during the five trading day period commencing on the date a put notice requesting that a third party purchase. On July 19, 2012, the Company received proceeds of $6,000 for the sale of 701,754 shares of common stock pursuant to the Equity Purchase Agreement with a third party. The registration statement is no longer effective.
	During the six months ended December 31, 2013, the company issued 632,164,295 shares pursuant to the conversion of debt.

OPTIONS_WARRANTS_AND_STOCKBASE

OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION	6 Months Ended
	Dec. 31, 2013
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION:	'
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION	'
	6.  OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION
	2011 Equity Incentive Plan
	On March 4, 2011, the Board of Directors adopted the 2011 Equity Incentive Plan and reserved up to 50,000,000 shares of common stock for issuance to employees, directors and consultants, subject to stockholder approval.  On February 17, 2012, the stockholders approved the plan.  The plan also provides for automatic annual increases on January 1st of each year (commencing on January 1, 2012 and ending on January 1, 2021), in the aggregate number of shares reserved equal to the lesser of (a) five percent of the total number of shares outstanding on December 31st of the preceding year or (b) 3,000,000 shares.  As of January 1, 2013, the number of shares reserved under the plan automatically increased to 56,000,000.  Under the plan, the Board may grant stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other stock awards.
	Valuation and amortization method. The fair value of each stock award is estimated on the grant date using the Black-Scholes option-pricing model.  The estimated fair value of employee stock options is amortized to expense using the straight-line method over the vesting period.
	Volatility. The Company estimates volatility based on the Company’s historical volatility.
	Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.
	Expected term. The expected term of stock options granted is based on an estimate of when options will be exercised in the future.  The Company applied the simplified method of estimating the expected term of the options, as described in the SEC’s Staff Accounting Bulletins 107 and 110, as the Company has had a significant change in its business operations and the historical experience is not indicative of the expected behavior in the future.  The expected term, calculated under the simplified method, is applied to groups of stock options that have similar contractual terms.  Using this method, the expected term is determined using the average of the vesting period and the contractual life of the stock options granted.
	Forfeitures.   Stock-based compensation expense is recorded only for those awards that are expected to vest.  FASB ASC Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option.  An annual forfeiture rate of 0% was applied to all unvested options as of December 31, 2013 which was management’s best estimate.  This analysis will be re-evaluated semi-annually and the forfeiture rate will be adjusted as necessary.  Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.
	The following weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:
			Six Months		Six Months
			Ended		Ended
			31-Dec-13		December 31, 2012
	Risk-free interest rate		0.62% - 0.72%		0.90% - 0.96%
	Expected dividend yield		—		—
	Expected term		3.25 - 5.5 years		5.5 years
	Forfeiture rate		0%		0%
	Expected volatility		244.90% - 262.52%		122.33% - 124.91%
	A summary of option activity as of December 31, 2013 and for the three months then ended is presented below:
	Options		Shares		Weighted-			Weighted-	Aggregate
					Average			Average	Intrinsic
					Exercise			Remaining	Value
					Price			Contractual
								Term
	Outstanding at July 1, 2013		46,690,000		$	0.062		8.83 years	$	588
	Granted		240,000			0.008
	Exercised		—		$	—
	Forfeited or expired		—		$	—		—		—
	Outstanding at December 31, 2013		46,930,000		$	0.062		7.34years	$	—
	Exercisable at December 31, 2013		16,843,000		$	0.057		7.34 years	$	—
	On August 6, 2012, the Board of Directors granted stock options to purchase 120,000 shares of common stock at an exercise price of $0.0067.  The weighted average fair value of the options on the grant date was estimated at $0.0067 per share. These options vest over one year and have a contractual term of 10 years.
	On September 6, 2012, the Board of Directors granted stock option to purchase 120,000 shares of common stock at an exercise price of $0.009.  The weighted average fair value of the options on the grant date was estimated at $0.009 per share. These options vest over one year and have a contractual term of 10 years.
	Stock-based compensation expense for options for the three months ended december 31, 2013 and 2012 was $133,508 and $133,701 respectively.. At September 30, 2013, unrecognized total compensation cost related to all unvested awards of $299,490 is expected to be recognized over a weighted average period of .81 years.
	On March 15, 2012, the Company agreed to issue a restricted stock award of 2,500,000 shares of common stock to a consultant for services to be rendered with 1,250,000 shares vesting on June 15, 2012 and 1,250,000 shares vesting on September 15, 2012.  Consulting expense recorded for the restricted stock award was $20,833 for the three months ended September 30, 2013.
	At December 30, 2013 there were 6,570,000 shares reserved for future grants.
	Warrants
	No warrants were exercised during the three months ended September 30, 2013.    During the three months ended September 30, 2013, the Company issued 570,000 warrants in connection with convertible notes payable (see Note 3).  The warrants have an exercise price of $0.01 per share, are immediately exercisable and expire in five years. The Company has reserved 2,645,000 shares of common stock for the exercise of outstanding warrants.  The following table summarizes the warrants outstanding at September 30, 2013:
	Exercise price			Number			Expiration Date
	$	5.85			75,000		8/3/13
		0.01			500,000		2/10/17
		0.01			1,000,000		2/17/17
		0.01			500,000		4/18/17
		0.01			20,000		8/15/17
		0.01			50,000		8/20/17
		0.01			250,000		9/14/17
		0.01			250,000		10/2/17
					2,645,000
	The weighted average grant date fair value of the warrants granted during the three months ended September 30, 2013 was $0.0095 per share.  The warrants were valued using the Black-Scholes option pricing model.  The following assumptions were used for warrants issued during the three months ended September 30, 2013; risk free interest rates of 0.60% - 0.72%; expected dividend yield of 0%; expected term of 5 years and expected volatility of  244.07% - 248.52%.  The weighted average remaining life of the warrants at December 31, 2013 was 3.86 years.  At December 31, 2013, all warrants are exercisable and there is no aggregate intrinsic value for the warrants outstanding.
	Stock Award Plan
	Under the 2006 Stock Award Plan the Company may award shares of common stock to employees, officers, directors, consultants and advisors and may make grants subject to such terms and conditions as determined by the Board of Directors. As of September 30, 2013, the Company has 111,845 shares available for future grant under the Plan.

NET_LOSS_PER_SHARE

NET LOSS PER SHARE	6 Months Ended
	Dec. 31, 2013
NET LOSS PER SHARE.	'
NET LOSS PER SHARE	'
	7.  NET LOSS PER SHARE
	Securities that could potentially dilute basic earnings (loss) per share ("EPS") as of December 31, 2013 and 2012, and that were not included in the computation of diluted EPS because to do so would have been anti-dilutive for the three and six months ended December 30, 2013 and 2012 consist of the following:
			Shares Potentially Issuable
		31-Dec-13			30-Jun-13
	Series E Convertible Preferred Stock			-0-		2,251,391
	Series F Convertible Preferred Stock			45,000,000		45,000,000
	Series G Convertible Preferred Stock			-0-		-0-
	Series H Convertible Preferred Stock			506,091,003		183,756,751
	Convertible notes payable			3,565,468,889		332,000,000
	Stock options			46,690,000		46,690,000
	Restricted stock award			2,500,000		2,500,000
	Warrants			2,650,000		2,650,000
	Total			4,168,394,892		614,843,142

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Dec. 31, 2013
COMMITMENTS AND CONTINGENCIES	'
COMMITMENTS AND CONTINGENCIES	'
	8.  COMMITMENTS AND CONTINGENCIES
	Operating Lease
	Currently, the Company rents space at 850 3rd Avenue in New York City on a month-to-month basis.  Monthly rent approximates $2,000.  There are no future minimum lease rental payments.
	On December 7, 2011, the Company entered into a one-year lease for 1,957 square feet in Gaithersburg, Maryland which expires on September 30, 2013.  On November 16, 2012, the Company extended the lease for one year.  Monthly lease amounts for this facility in 2013 total approximately $2,018 including monthly operating expense charges of $781.
	Consulting Agreements
	The Company signed a consulting agreement which calls for a $30,000 monthly payment in the form of a convertible promissory note.  For the three and six months ended December 31, 2013, the Company has incurred $90,000 and $180,000 in consulting expenses, respectively. See Footnote 3 for details on the Notes issued for these services.

EMPLOYEE_BENEFIT_PLAN

EMPLOYEE BENEFIT PLAN	6 Months Ended
	Dec. 31, 2013
EMPLOYEE BENEFIT PLAN:	'
EMPLOYEE BENEFIT PLAN	'
	9. EMPLOYEE BENEFIT PLAN
	The Company has a 401(k) plan for the benefit of certain employees. The Company had contributed to the plan under a safe harbor plan requiring a 3% contribution for all eligible participants. In addition, the Company may contribute a 3% elective match.  Effective January 1, 2013, the Company amended the plan to remove the 3% safe harbor contribution.  No contributions have been made in the current fiscal year. Contributions and other costs of the plan for the three months ended December 31, 2013 were $-0-. Contributions and other costs of the plan for the six months ended December 31, 2012 were $1,632.

OPERATING_SEGMENTS

OPERATING SEGMENTS	6 Months Ended
	Dec. 31, 2013
OPERATING SEGMENTS	'
OPERATING SEGMENTS	'
	10.  OPERATING SEGMENTS
	The Company operates in two operating segments which are consistent with its internal organization. The major segments are medical diagnostic services and government contracting.  The government contracting segment became inactive during the three months ended September 30, 2013.  Where applicable, “Unallocated” represents items necessary to reconcile to the consolidated financial statements, which generally include corporate activity at the parent level and eliminations.
	The Company evaluates performance of individual operating segments based on operating income (loss). On a consolidated basis, this amount represents total net loss as shown in the consolidated statement of operations. Reconciling items represent executive compensation costs that are not allocated to the operating segments.  Such costs have not been allocated from the parent to the subsidiaries.
		Three Months Ended December 31, 2013
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	54,000		$	-		$	-		$	54,000
	Operating income (loss)		-9,853			(478	)		(302,676	)		-313,007
	Other income (expense)		-			-			-310,836	)		-310,836
	Interest expense		-			-			101,709			101,709
	Depreciation and amortization		4,282			498			-			4,780
	Expenditure for long-lived assets, including intangibles		-			-			-			-
	Total Assets at December 31, 2013		67,282			5,916			1,039,074			1,112,272
		Three Months Ended December 31, 2012
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	136,723		$	-		$	-		$	136,723
	Operating income (loss)		34,813			(143,827	)		(69,583	)		(178,597	)
	Other income (expense)		-			22,761			(30,648	)		-7,887
	Interest expense		4,321			64,222			-			68,543
	Depreciation and amortization		2,698			-			-			2,698
	Expenditure for long-lived assets, including intangibles		14,100			-			-			14,100
		Six Months Ended December 31, 2013
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	108,000		$	-		$	-		$	108,000
	Operating income (loss)		(34,827	)		(956	)		(568,740	)		(604,523	)
	Other income (expense)		6,501			-			(310,836	)		(304,335	)
	Interest expense		-				-		167,932			167,932
	Depreciation and amortization		8,564			896			-			9,760
	Expenditure for long-lived assets, including intangibles		-			-			-			-
	Total Assets at December 31, 2013		67,282			5,916			1,039,074			1,112,272
		Six Months Ended December 31, 2012
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	191,706		$	-		$	-		$	191,706
	Operating income (loss)		(16,099	)		(349,361	)		(279,544	)		(645,004	)
	Other income (expense)		-			33,001			(30,648	)		2,353
	Interest expense		13,769			119,699			-			133,468
	Depreciation and amortization		5,396			-			-			5,396
	Expenditure for long-lived assets, including intangibles		28,200			-			-			28,200
	Total Assets at December 31, 2012		210,255			18,671			-			228,926

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Dec. 31, 2013
SUBSEQUENT EVENTS	'
SUBSEQUENT EVENTS	'
	11.  SUBSEQUENT EVENTS
	Issuance of Debt
	On January 1, 2014, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on July 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On February 1, 2014, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on August 31, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On February 28, 2014, an Investor advanced the Company $5,000 in a Promissory Note.  The Promissory Note matures on March 31, 201,has an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The Promissory Note has a face value of $5,500, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date.
	On March 1, 2014, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on September 30, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	On April 1, 2014, the Company issued a note for $30,000 for consulting services.    The convertible promissory note bears no interest and matures on October 31,, 2014. The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to 50% of the lowest closing bid price for the twenty days prior to the conversion. The Company recorded a beneficial conversion discount of $30,000 based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.  As of the date of this filing, there have been no conversions of this Note and the entire amount is outstanding.
	Certificate of Amendment of Certificate of Incorporation
	On April 1, 2014, the Company filed a Certificate of Amendment to its Certificate of Incorporation stating as follows:
	The total number of shares of all classes of stock which the Corporation shall have the authority to issued is Ten Billion (10,000,000,000) of which 9,950,000,000 shares of a par value of $.001 shall be designated “Common Shares” and 5,000,000 shares of a par value $.001 shall be designated “Preferred Shares.”

Notes_payable_Related_parties_

Notes payable Related parties and a Third parties (TABLE)	6 Months Ended
	Dec. 31, 2013
Notes payable Related parties and a Third parties (TABLE):	'
Notes payable Related parties and a Third parties (TABLE)	'
	otes payable – related parties and a third parties consist of the following:
		December 31,		June 30,
		2013		2013
	Note payable – former Managing Member	$	27,750	$	27,750
	Note payable – related corporation		4,300		4,300
	Notes payable – stockholders		13,000		13,000
	Convertible notes payable		805,355		500,308
	Total		850,405		545,358
	Convertible notes payable, discount		-181,629		-43,619
	Total, net of discount		668,776		501,739
	Less current portion		668,776		384,785
	Long-term debt	$	-0-	$	116,954

OPTIONS_WARRANTS_AND_STOCKBASE1

OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION(TABLE)	6 Months Ended
	Dec. 31, 2013
OPTIONS, WARRANTS AND STOCK-BASED COMPENSATION(TABLE):	'
Fair value of Stock Options Using the Black-Scholes Option Pricing Model(TABLE)	'
	The following weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:
			Six Months		Six Months
			Ended		Ended
			31-Dec-13		December 31, 2012
	Risk-free interest rate		0.62% - 0.72%		0.90% - 0.96%
	Expected dividend yield		—		—
	Expected term		3.25 - 5.5 years		5.5 years
	Forfeiture rate		0%		0%
	Expected volatility		244.90% - 262.52%		122.33% - 124.91%
Summary of Option Activity (TABLE)	'
	A summary of option activity as of December 31, 2013 and for the three months then ended is presented below:
	Options		Shares		Weighted-			Weighted-	Aggregate
					Average			Average	Intrinsic
					Exercise			Remaining	Value
					Price			Contractual
								Term
	Outstanding at July 1, 2013		46,690,000		$	0.062		8.83 years	$	588
	Granted		240,000			0.008
	Exercised		—		$	—
	Forfeited or expired		—		$	—		—		—
	Outstanding at December 31, 2013		46,930,000		$	0.062		7.34years	$	—
	Exercisable at December 31, 2013		16,843,000		$	0.057		7.34 years	$	—
Summary of Warrants Outstanding (TABLE)	'
	The following table summarizes the warrants outstanding at September 30, 2013:
	Exercise price			Number			Expiration Date
	$	5.85			75,000		8/3/13
		0.01			500,000		2/10/17
		0.01			1,000,000		2/17/17
		0.01			500,000		4/18/17
		0.01			20,000		8/15/17
		0.01			50,000		8/20/17
		0.01			250,000		9/14/17
		0.01			250,000		10/2/17
					2,645,000
	T

COMPUTATION_OF_DILUTED_EPS_TAB

COMPUTATION OF DILUTED EPS (TABLE)	6 Months Ended
	Dec. 31, 2013
COMPUTATION OF DILUTED EPS (TABLE):	'
COMPUTATION OF DILUTED EPS (TABLE)	'
			Shares Potentially Issuable
		31-Dec-13			30-Jun-13
	Series E Convertible Preferred Stock			-0-		2,251,391
	Series F Convertible Preferred Stock			45,000,000		45,000,000
	Series G Convertible Preferred Stock			-0-		-0-
	Series H Convertible Preferred Stock			506,091,003		183,756,751
	Convertible notes payable			3,565,468,889		332,000,000
	Stock options			46,690,000		46,690,000
	Restricted stock award			2,500,000		2,500,000
	Warrants			2,650,000		2,650,000
	Total			4,168,394,892		614,843,142

Evaluating_Performanc_of_Indiv

Evaluating Performanc of Individual Operating Segments (TABLE)	6 Months Ended
	Dec. 31, 2013
Evaluating Performanc of Individual Operating Segments (TABLE):	'
Evaluating Performanc of Individual Operating Segments (TABLE)	'
		Three Months Ended December 31, 2013
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	54,000		$	-		$	-		$	54,000
	Operating income (loss)		-9,853			(478	)		(302,676	)		-313,007
	Other income (expense)		-			-			-310,836	)		-310,836
	Interest expense		-			-			101,709			101,709
	Depreciation and amortization		4,282			498			-			4,780
	Expenditure for long-lived assets, including intangibles		-			-			-			-
	Total Assets at December 31, 2013		67,282			5,916			1,039,074			1,112,272
		Three Months Ended December 31, 2012
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	136,723		$	-		$	-		$	136,723
	Operating income (loss)		34,813			(143,827	)		(69,583	)		(178,597	)
	Other income (expense)		-			22,761			(30,648	)		-7,887
	Interest expense		4,321			64,222			-			68,543
	Depreciation and amortization		2,698			-			-			2,698
	Expenditure for long-lived assets, including intangibles		14,100			-			-			14,100
		Six Months Ended December 31, 2013
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	108,000		$	-		$	-		$	108,000
	Operating income (loss)		(34,827	)		(956	)		(568,740	)		(604,523	)
	Other income (expense)		6,501			-			(310,836	)		(304,335	)
	Interest expense		-				-		167,932			167,932
	Depreciation and amortization		8,564			896			-			9,760
	Expenditure for long-lived assets, including intangibles		-			-			-			-
	Total Assets at December 31, 2013		67,282			5,916			1,039,074			1,112,272
		Six Months Ended December 31, 2012
		Medical			Government			Unallocated			Total
		Diagnostics			Contracting
	Revenues	$	191,706		$	-		$	-		$	191,706
	Operating income (loss)		(16,099	)		(349,361	)		(279,544	)		(645,004	)
	Other income (expense)		-			33,001			(30,648	)		2,353
	Interest expense		13,769			119,699			-			133,468
	Depreciation and amortization		5,396			-			-			5,396
	Expenditure for long-lived assets, including intangibles		28,200			-			-			28,200
	Total Assets at December 31, 2012		210,255			18,671			-			228,926

NATURE_OF_OPERATIONS_AND_BASIS1

NATURE OF OPERATIONS AND BASIS OF PRESENTATION Digipath Solutions, LLC (Details) (USD $)	Dec. 31, 2013	Oct. 25, 2013	Sep. 18, 2012
Digipath Solutions, LLC	'	'	'
As per Equity Purchase Agreement, the Company issued Mr. Reddy a convertible promissory note in the amount of	'	'	$1,050,000
Shares of Series G Preferred Stock (the "Shares"), and agreed to make a cash payment	'	'	1,250
Value of Series G Preferred Stock	'	'	100,000
Amount paid by Digipath	'	'	50,000
Company pursuant to which he agreed to perform consulting and advisory services in the field of pathology and to serve as a member of the Company's Medical Advisory Board for a monthly retainer of	'	'	8,333
The Company also recognized a loss on the terminated acquisition of	30,648	'	'
The equity holders of EIP will become the holders of approximately % of the total outstanding capital stock, on a fully diluted basis	'	76.00%	'
AccelPath acquired, from EIP, shares of Common Stock of EIP representing % of the issued and outstanding Common Stock	'	19.00%	'
AccelPath acquired, from EIP, shares of Common Stock in return for shares of a newly created Series I Preferred Stock of AccelPath	'	3,500	'
% owned subsidiary Technest, Inc.	49.00%	'	'
% owned subsidiary Genex Technologies, Inc and Accelpath LLC.	100.00%	'	'
Based upon a report of an independent valuation analyst, the Company valued its investment in EIP at	$1,039,074	'	'

GOING_CONCERN_UNCERTAINTY_AND_1

GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN TEXT (DETAILS) (USD $)	Dec. 31, 2013	Jun. 30, 2013
GOING CONCERN UNCERTAINTY AND MANAGEMENT'S PLAN TEXT	'	'
Net Loss Applicable to Common Shareholders.	$1,076,791	$2,342,309
Working Capital Deficit	3,039,043	'
Total Stockholders' Deficit.	$1,930,812	'

Recovered_Sheet1

Notes payable - related parties and a third parties consist of the following: (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Notes payable - related parties and a third parties consist of	'	'
Note payable - former Managing Memmber	$27,750	$27,750
Note payable - related corporation	4,300	4,300
Notes payable - stockholders	13,000	13,000
Convertible notes payable.	805,355	500,308
Total convertible notes payable.	850,405	545,358
Convertible notes payable, discount	-181,629	-43,619
Total, net of discount	668,776	501,739
Less current portion	668,776	384,785
Long-term debt.	0	116,954
Maturities of notes payable for the years ending June 30, 2014	634,003	'
Maturities of notes payable for the years ending June 30, 2015	$216,402	'

Notes_payable_paretheticals_De

Notes payable paretheticals (Details) (USD $)	3 Months Ended			6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2013	Dec. 31, 2012
Notes payable paretheticals	'	'	'	'	'
Consulting expense for the period	$750	'	$3,000	'	'
Company borrowed a sum from a stockholder	'	'	15,000	'	'
Company borrowed from our Chief Executive Officer	'	'	5,000	'	'
Company borrowed an additional sum from our Chief Executive Officer.	'	'	34,700	'	'
The balance of these notes are payable on demand and accrue interest at % per annum.	'	'	19.00%	'	'
Amortization of discount on the convertible notes and accrual of the Original Issue Discount was	101,709	68,543	'	'	'
Interest expense on notes payable, including amortization of the discount on the convertible notes and the accrual of the redemption premium, was .	'	'	'	167,932	133,468
Fair value of the warrant was recognized as an additional debt discount and fully amortized to interest expense	'	'	$3,431	'	'
Third party converted the entire principal value of the note plus $1,692 of accrued interest into shares of common stock.	'	'	48,770,841	'	'

Notes_Payable_Details_Details

Notes Payable Details (Details) (USD $)

Dec. 01, 2013

Nov. 01, 2013

Oct. 09, 2013

Oct. 02, 2013

Sep. 20, 2013

Sep. 05, 2013

Sep. 01, 2013

Aug. 01, 2013

Jul. 02, 2013

Mar. 22, 2013

Mar. 13, 2013

Sep. 14, 2012

Aug. 31, 2012

Jul. 31, 2012

Jul. 18, 2012

Notes Payable Details

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Company entered into an agreement with a third party to exchange 100 shares of Series E Preferred Stock and accrued dividends of

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5,834

Issue of convertible promissory note in the principal amount of

'

'

'

'

'

'

'

'

'

'

'

'

'

'

105,834

The note accrues interest at a rate of % per annum

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

5.00%

Third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to % of the current market price

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

60.00%

The Company recorded a beneficial conversion discount of

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70,556

Allocated sum of the proceeds to the discounted value of the note

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35,278

Third party converted the entire principal value of the note plus of accrued interest of

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,692

Third party converted the entire principal value of the note plus of accrued interest into shares of common stock.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

48,770,841

Company borrowed a total amount from two individuals

'

'

'

'

'

'

'

'

'

'

'

'

'

7,000

'

The Company also issued the investors a five-year warrant to purchase a total shares of common stock at an exercise price of $0.01 per share

'

'

'

'

'

'

'

'

'

'

'

'

'

70,000

'

Company allocated the proceeds to the warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

443

'

Allocated sum of the proceeds to the discounted value of the note based on their relative fair values

'

'

'

'

'

'

'

'

'

'

'

'

'

6,557

'

Investors converted their notes into shares of common stock

'

'

'

'

'

'

'

'

'

'

'

'

700,000

'

'

Company borrowed from a stockholder.

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

The convertible promissory note bears interest at an interest rate per annum and matures on March 14, 2014

'

'

'

'

'

'

'

'

'

5.00%

'

5.00%

'

'

'

The Company also issued the investor a five-year warrant to purchase a total shares of common stock at an exercise price of $0.01 per share

'

'

'

'

'

'

'

'

'

'

'

250,000

'

'

'

The Company allocated the proceeds to the warrants

'

'

'

'

'

'

'

'

'

'

'

1,536

'

'

'

Allocated the proceeds to the discounted value of the note based on their relative fair values.

'

'

'

'

'

'

'

'

'

11,667

'

23,464

'

'

'

Company borrowed from a a third party.

'

'

'

'

'

'

'

'

'

35,000

10,000

'

'

'

'

The Company recorded a beneficial conversion discount of based on the fair value of the common stock into which the note is convertible to

30,000

30,000

'

30,000

'

'

30,000

30,000

30,000

23,333

10,000

'

'

'

'

The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to % of the lowest closing bid price for the ten days prior to the conversion

50.00%

50.00%

'

50.00%

'

'

50.00%

50.00%

50.00%

'

50.00%

'

'

'

'

Company issued a note for consulting services / for fees.

30,000

30,000

79,000

30,000

'

'

30,000

30,000

30,000

'

'

'

'

'

'

Investor advanced the company a promissory note

'

'

'

'

'

15,000

'

'

'

'

'

'

'

'

'

Face value of the promissory note

'

'

86,900

'

'

17,500

'

'

'

'

'

'

'

'

'

Amount of the balance of the note with the OID accrued was

'

'

'

'

15,174

'

'

'

'

'

'

'

'

'

'

Market Price" is defined as % of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date

'

'

50.00%

'

50.00%

50.00%

'

'

'

'

'

'

'

'

'

Investor exchanged its remaining interest,in the Series E 5% convertible Preferred stock

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

Amount of accrued dividends of

'

'

'

'

14,282

'

'

'

'

'

'

'

'

'

'

Value of a new Secured Note for

'

'

'

'

$114,282

'

'

'

'

'

'

'

'

'

'

NOTES_PAYABLE_TEXTUALS_DETAILS

NOTES PAYABLE TEXTUALS (DETAILS) (USD $)	Dec. 31, 2013	Oct. 31, 2013	Jul. 18, 2012	Apr. 18, 2012	Feb. 17, 2012	Feb. 10, 2012	Aug. 18, 2011	Mar. 04, 2011
NOTES PAYABLE TEXTUALS	'	'	'	'	'	'	'	'
The Managing Member resigned on Mar. 4, 2011 and AccelPath agreed to repurchase shares of $0.001 par value common stock	'	'	'	'	'	'	'	10,498,120
The Managing Member resigned on Mar. 4, 2011 and AccelPath agreed to repurchase shares of $0.001 par value common stock for a value of	'	'	'	'	'	'	'	$74,000
To complete the repurchase, AccelPath issued a note payable due in eight monthly installments including interest at 0.54% per annum	'	'	'	'	'	'	74,000	'
AccelPath issued note payable due in eight monthly installments of	'	'	'	'	'	'	9,269	'
AccelPath has not paid principal payments due for August through October 2011	27,750	'	'	'	'	'	'	'
AccelPath entered into a consulting agreement with the Managing Member requiring payments of amount per month for a period of eight months in consideration for continuing services.	750	'	'	'	'	'	'	'
AccelPath has accrued but not made the amount of consulting payments due for August through October 2011.	2,250	'	'	'	'	'	'	'
Company borrowed from a corporation controlled by our Chief Executive Officer.	'	'	'	'	'	'	3,300	'
The Company borrowed an additional sum on January 12, 2012.	'	'	'	'	'	'	1,000	'
The note is payable on demand and accrues interest at a rate of % per annum.	'	'	'	'	'	'	0.32	'
Company repaid the note payable - stockholder	'	'	'	'	'	2,000	'	'
The balance of this note is payable on demand and accrues interest at % per annum	'	'	'	'	'	19.00%	'	'
Company borrowed amount from a stockholder	'	100,000	'	'	'	'	'	'
The loan will be repaid with three monthly payments of	'	23,000	'	'	'	'	'	'
Payment of total amount of	'	138,000	'	'	'	'	'	'
Company borrowed from a third party under a promissory note which matured on August 31, 2012	'	'	'	'	'	40,000	'	'
The note bears interest at 8% per annum and includes a redemption premium of due on the maturity date.	'	'	'	'	'	6,000	'	'
Company borrowed from a third party	'	'	'	'	'	50,000	'	'
The Company repaid of the note on March 12, 2012	'	'	'	'	'	5,000	'	'
The convertible promissory note bears interest at % per annum	'	'	'	'	'	5.00%	'	'
The Company also issued the investor a five-year warrant to purchase shares of common stock at an exercise price of $0.01 per share	'	'	'	'	1,000,000	500,000	'	'
The Company allocated sum of the proceeds to the warrant	'	'	'	8,225	32,743	8,037	'	'
Allocated sum of the proceeds to the discounted value of the note based on their relative fair values	'	'	'	'	'	41,963	'	'
Company entered into an amendment to the agreement to extend the maturity date to November 10, 2012 in exchange for a payment of	'	'	'	'	'	2,000	'	'
Issuance of a warrant to purchase shares of common stock at an exercise price of $0.01 per share	'	'	'	'	'	250,000	'	'
Fair value of the warrant was recognized as an additional debt discount and fully amortized to interest expense during the period	'	'	'	'	'	3,431	'	'
Payment was made in January 2013.	'	'	'	'	'	2,000	'	'
Company borrowed from a a third party	'	'	'	'	100,000	'	'	'
The convertible promissory note bears interest at % per annum and matures on August 16, 2013	'	'	'	'	5.00%	'	'	'
Allocated sum of the proceeds to the discounted value of the note based on their relative fair values.	'	'	70,667	41,775	67,257	'	'	'
Company borrowed from a a third party, Convertible Promissory note	'	'	100,000	50,000	'	'	'	'
The convertible promissory note bears interest at % per annum and matures on October 17, 2013	'	'	5.00%	5.00%	'	'	'	'
The Company also issued the investor a five-year warrant to purchase shares of common stock	'	'	'	500,000	'	'	'	'
The Company also issued the investor a five-year warrant to purchase shares of common stock at an exercise price of	'	'	$0.01	$0.01	'	'	'	'
The Company recorded a beneficial conversion discount of based on the fair value of the common stock	'	'	$29,333	'	'	'	'	'

COMMON_STOCK_ISSUANCES_Details

COMMON STOCK ISSUANCES (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Jul. 19, 2012	Mar. 07, 2011
COMMON STOCK ISSUANCES	'	'	'
Issuance of common stock (in shares) pursuant to Equity Purchase Agreement with a third party	'	701,754	5,000,000
Proceeds from issuance of common stock.	'	$6,000	'
The company issued shares pursuant to conversion of debt.	632,164,295	'	'

PREFERRED_STOCK_Text_Details

PREFERRED STOCK Text (Details) (USD $)	3 Months Ended				6 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2013	Dec. 31, 2012	Apr. 03, 2013	Sep. 18, 2012	Sep. 10, 2012	Sep. 07, 2012
PREFERRED STOCK Text	'	'	'	'	'	'	'	'	'	'
Company exchanged its remaining 100 shares of Series E Preferred Stock plus $14,282 of accrued dividends into a new Secured Note of	'	$114,282	'	'	'	'	'	'	'	'
The Company accrued cash dividends payable on the Series E Preferred of	'	1,138	'	1,528	'	'	'	'	'	'
Accrued Dividends payable are included in accrued expenses and other current liabilities	0	'	1,278	'	1,139	2,806	'	'	'	'
Company authorized issue of shares of Series F Convertible Preferred Stock,	'	'	'	'	'	'	'	'	'	100
Company authorized 100 shares of Series F Convertible Preferred Stock, with a stated value of	'	'	'	'	'	'	'	'	'	1,000
Conversion Price shall be	'	'	'	'	'	'	'	$0.02	'	$0.02
Accordingly, the authorized 100 shares of Series F Preferred are currently convertible into shares of common stock using a Conversion Price of $0.02.	'	'	'	'	'	'	'	'	'	50,000,000
Company issued 90 shares of its Series F Preferred Stock for the purchase price of $ to certain existing investors of the Company	'	'	'	'	'	'	'	'	90,000	'
The 90 shares of Series F Preferred are currently convertible into shares of common stock	'	'	'	'	'	'	'	'	45,000,000	'
The Company determined that there was a beneficial conversion feature for the issuance of the 90 shares of Series F Preferred Stock.	'	'	'	'	'	'	'	'	360,000	'
This resulted in a deemed dividend in the amount of	'	360,000	'	'	'	'	'	'	'	'
Company authorized shares of Series G Convertible Preferred Stock,	'	'	'	'	'	'	'	1,250	'	'
Company authorized shares of Series G Convertible Preferred Stock, with a stated value of	'	'	'	'	'	'	'	$1,000	'	'
The authorized 1,250 shares of Series G Preferred are convertible into shares of common stock at an assumed Conversion Price of $0.02.	'	'	'	'	'	'	'	62,500,000	'	'
Series H Stockholder holds in the aggregate approximately % of the total voting power of all issued and outstanding voting capital of the Company	'	'	'	'	'	'	51.00%	'	'	'
Series H Preferred was convertible into shares of common stock.	'	'	'	'	'	'	506,091,003	'	'	'
Series I may be convertible into % of the outstanding shares of the Company on a fully diluted basis.	14.00%	'	'	'	'	'	'	'	'	'
shares issued and outstanding of the Series I Preferred.	3,500	'	'	'	'	'	'	'	'	'

Options_warrants_and_stock_bas

Options, warrants and stock based compensation Parentheticals (Details) (USD $)	3 Months Ended
	Sep. 30, 2013	Dec. 31, 2013
Options, warrants and stock based compensation Parentheticals	'	'
Consulting expense recroded for restricted stock award	$20,833	'
Shares reserved for future grant	'	6,570,000
Stock based compensation expense for options	133,508	'
Unrecognized total compensation related cost related to unvested awards	$299,490	'
To be recognized over a weighted average period in years	0.81	'
Company issued warrants in connection with convertible notes payable with an exercise price of $0.01 per share.	570,000	'
The warrants are immediately exercisable and expire in years.	5	'
The Company has reserved shares of common stock for the exercise of outstanding warrants.	2,645,000	'
Company has shares available for future grant under the Plan.	111,845	'

Weighted_average_assumptions_w

Weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model: (Details)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Weighted average assumptions were used to estimate the fair value of stock options using the Black-Scholes option pricing model:	'	'
Risk-free interest rate Minimum	0.62%	0.90%
Risk-free interest rate Maximum	0.72%	0.96%
Expected dividend yield	0	0
Expected term	'3.25 - 5.5 years	'5.5 years
Forfeiture rate	0.00%	0.00%
Expected volatility Minimum	244.90%	122.33%
Expected volatility maximum	262.52%	124.91%

Weighted_average_assumptions_w1

Weighted average assumptions were used to estimate the fair value of warrants granted using the Black-Scholes option pricing model: (Details) (USD $)	3 Months Ended
	Sep. 30, 2013
Weighted average assumptions were used to estimate the fair value of warrants granted using the Black-Scholes option pricing model:	'
Risk-free interest rate Minimum.	0.60%
Risk-free interest rate Maximum.	0.72%
Expected dividend yield.	0.00%
Expected term.	3.86
Forfeiture rate.	$0.01
Expected volatility Minimum.	244.07%
Expected volatility maximum.	248.52%

The_following_table_summarizes

The following table summarizes the warrants outstanding (Details) (Number of warrants)	Dec. 31, 2013
Number of warrants	'
Warrants outstanding with exercise price range of $5.85 per share with expiration date of Aug. 8, 2013	75,000
Warrants outstanding with exercise price range of $5.85 per share with expiration date of Aug. 8, 2013	75,000
Warrants outstanding with exercise price range of $0.01 per share, expiring on Feb.10, 2017	500,000
Warrants outstanding with exercise price range of $0.01 per share.expiring on Feb.17, 2017	1,000,000
Warrants outstanding with exercise price range of $0.01 per share expiring on Apr.18, 2017	500,000
Warrants outstanding with exercise price range of $0.01 per share,, expiring on Aug. 15, 2017	20,000
Warrants outstanding with exercise price range of $0.01 per share., expiring August 20, 2017	50,000
Warrants outstanding with exercise price range of $0.01 per share,. Expiring on Sept. 14, 2017	250,000
Warrants outstanding with exercise price range of $0.01 per share.'' expiring on Oct 2, 2017	250,000
Total warrants outstanding	2,645,000

A_summary_of_option_activity_D

A summary of option activity (Details)	Shares	Weighted Average Exercise price	Weighted Average Remaining contract term	Aggregate Intrinsic value
Outstanding options at Jun. 30, 2013	46,690,000	0.062	8.83	588
Granted	240,000	0.008	'	'
Exercised	0	'	'	'
Forfeited or expired	0	'	'	'
Exercisable options at Dec. 31, 2013	16,843,000	0.057	7.34	'
Outstanding Options. at Dec. 31, 2013	46,930,000	0.062	7.34	'

Options_warrants_and_stock_bas1

Options, warrants and stock based compensation Text (Details) (USD $)	Sep. 06, 2013	Aug. 06, 2013	Jan. 02, 2013	Mar. 15, 2012	Mar. 04, 2011
Options, warrants and stock based compensation text	'	'	'	'	'
Board of directors adopted Equity Incentive plan and reserved shares of common stock for issuance to employees, directors and consultants	'	'	'	'	50,000,000
The plan also provides for automatic annual increases on January 1st of each year five percent of the total number of shares outstanding on Dec.31st of preceding year or	'	'	'	'	300,000
The number of shares reserved under the plan automatically increased to	'	'	56,000,000	'	'
Board of Directors granted stock options to purchase shares of common stock	120,000	120,000	'	'	'
The weighted average fair value of the options on the grant date was estimated at per share.	$0.01	$0.01	'	'	'
These options vest over one year and have a contractual term of years.	10	10	'	'	'
Company agreed to issue a restricted stock award of shares of common stock to a consultant for services to be rendered	'	'	'	2,500,000	'
Number of shares vesting on June 15, 2012	'	'	'	1,250,000	'
Number of shares vesting on September 15, 2012	'	'	'	1,250,000	'

NET_LOSS_PER_SHARE_Text_Detail

NET LOSS PER SHARE Text (Details)	Dec. 31, 2013	Jun. 30, 2013
Securities that potentially dilute basic earnings (loss) per share	'	'
Series E Convertible Preferred Stock	0	2,251,391
Series F Convertible Preferred Stock	45,000,000	45,000,000
Series G Convertible Preferred Stock	0	0
Series H Convertible Preferred Stock	506,091,003	183,756,751
Convertible notes payable	3,565,468,889	332,000,000
Stock options	46,690,000	46,690,000
Restricted stock award	2,500,000	2,500,000
Warrants	2,650,000	2,650,000
Total shares potentially diluted	4,168,394,892	614,843,142

Commitments_and_Contingencies_

Commitments and Contingencies Text (Details) (USD $)	Dec. 31, 2013
Operating Lease:	'
Company rents space at 850 3rd Avenue in New York City on a month-to-month basis. Monthly rent approximates	$2,000
Monthly lease amounts for this facility in 2013 total approximately $2,018 including monthly operating expense charges of	781
Monthly lease amounts for this facility in 2013 total approximately	2,018
Company signed a consulting agreement which calls for a monthly payment in the form of a convertible promissory note.	30,000
Company has incurred amount in expenses.	$180,000

EMPLOYEE_BENEFIT_PLAN_Textual_

EMPLOYEE BENEFIT PLAN Textual (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
EMPLOYEE BENEFIT PLAN Textual	'	'
Defined Contribution Plan, Employer Matching Contribution, Percent	3.00%	'
Defined Contribution Plan Employer Matching Contribution Additional Percent	3.00%	'
Pension and Other Postretirement Benefit Contributions.	'	$1,632

Reconciling_items_representing

Reconciling items representing executive compensation costs that are not allocated to the operating segments (Details) (USD $)	Medical Diagnostics	Government Contracting	Unallocated	Total
Total Segment Assets at Sep. 30, 2013	'	'	'	'
Segment Revenues	$54,000	'	'	$54,000
Segment Operating Income (loss)	-9,853	-478	-302,676	-313,007
Segment Other income (expense)	0	'	-310,836	-310,836
Segment Interest expense	'	'	101,709	101,709
Segment Depreciation and amortization	4,282	498	'	4,780
Segment Expenditure for long-lived assets, including intangibles	0	'	'	'
Total Segment Assets at Dec. 31, 2013	$67,282	$5,916	$1,039,074	$1,112,272

Subsequent_Events_Text_Details

Subsequent Events Text (Details) (USD $)	Apr. 02, 2014	Mar. 02, 2014	Feb. 28, 2014	Feb. 02, 2014	Jan. 02, 2014
Subsequent Events Text	'	'	'	'	'
Company issued a note for consulting services on the 1st of 1st of Jan., Feb., Mar of 2014 and April 2014	$30,000	$30,000	'	$30,000	$30,000
The third party has the option to convert all or a portion of the note plus accrued interest into common stock at a conversion price equal to % of the lowest closing bid price for the twenty days prior to the conversion	50.00%	50.00%	'	50.00%	50.00%
The Company recorded a beneficial conversion discount based on the fair value of the common stock into which the note is convertible to and allocated $-0- of the proceeds to the discounted value of the note.	30,000	30,000	'	30,000	30,000
Investor advanced the Company in a Promissory Note	'	'	5,000	'	'
The Promissory Note has a face value of	'	'	$5,500	'	'
The "Market Price" is defined as % of the lowest closing bid price for the thirty (30) days immediately preceding the conversion date.	'	'	5000.00%	'	'
Total Number of shares of all classes of stock which the corporation shall have authority to issue	10,000,000,000	'	'	'	'
Shares of a par value of $.001 shall be designated as common shares	9,950,000,000	'	'	'	'
Shares of a par value of $.001 shall be designated as preferred shares	5,000,000	'	'	'	'